Thomas H Brannagan III, MD
Professor of Clinical Neurology
Director, Peripheral Neuropathy Center
Columbia University College of Physicians and Surgeons
Co-director, Electromyography Laboratory
Columbia University Medical Center
Neurology, Clinical Neurophysiology and Electrodiagnostic Medicine
710 W 168th St
New York, NY 10032
Office Telephone: (212) 305-0405
EMG Appointments: (212) 305-1330
Office Fax: (212) 305-5396
Insurance: Aetna, Empire BC/BS, CIGNA, United Healthcare, Neighborhood, Oxford, Medicare, Medicare Railroad, Medicaid
*Please verify insurance participation with the physician's office when making an appointment.
» The Columbia Neuropathy Research Center
» The EMG Laboratory
» Department of Neurology
» Recent Publications
Dr. Brannagan is the director of the Peripheral Neuropathy Center at Columbia University Medical Center. He graduated from the University of Virginia and also received his medical degree from the University of Virginia in Charlottesville. He completed his Neurology residency training at the Neurological Institute of Columbia Presbyterian Medical Center between 1991 and 1994. He subsequently did a Neuromuscular EMG fellowship at Columbia, followed by a Neuroimmunology fellowship in the laboratory of Dr. Norman Latov. Prior to returning to Columbia, Dr. Brannagan was the director of the Diabetic Neuropathy Research center at Cornell University in New York City and was co-director of the EMG laboratory at MCP-Hahnemann University in Philadelphia.
He is a member of the American Academy of Neurology, as well as the American Association of Electrodiagnostic Medicine. He is also a member of the Neuropathy Association and the Peripheral Nerve Society.
Dr. Brannagan's major interest is in the evaluation and treatment of peripheral neuropathy, particularly immune-mediated neuropathies and idiopathic neuropathies. His publications have focused on new treatments for chronic demyelinating polyneuropathy (CIDP), painful neuropathies, neuropathy associated with celiac disease and the use of IVIg in Neurological disorders. He has participated in numerous clinical trials of new agents to treat patients with peripheral neuropathy.